Diversify Advisory Services LLC cut its holdings in Relx Plc (NYSE:RELX – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,542 shares of the technology company’s stock after selling 542 shares during the period. Diversify Advisory Services LLC’s holdings in Relx were worth $535,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in RELX. Benjamin F. Edwards & Company Inc. lifted its stake in Relx by 5.7% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,422 shares of the technology company’s stock worth $341,000 after purchasing an additional 403 shares in the last quarter. Profund Advisors LLC lifted its position in shares of Relx by 3.0% in the second quarter. Profund Advisors LLC now owns 14,007 shares of the technology company’s stock worth $643,000 after buying an additional 407 shares in the last quarter. Frank Rimerman Advisors LLC bought a new position in Relx during the second quarter valued at approximately $470,000. Evergreen Capital Management LLC grew its holdings in Relx by 3.8% during the 2nd quarter. Evergreen Capital Management LLC now owns 14,204 shares of the technology company’s stock valued at $652,000 after buying an additional 517 shares in the last quarter. Finally, Marshall Wace LLP bought a new stake in Relx in the 2nd quarter worth approximately $312,000. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Stock Up 2.8 %
NYSE:RELX opened at $49.53 on Wednesday. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63. The business has a 50 day simple moving average of $46.45 and a 200-day simple moving average of $46.61. Relx Plc has a 1 year low of $40.25 and a 1 year high of $49.57.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on RELX
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- How to Calculate Return on Investment (ROI)
- SAP’s Strong Momentum: A Bullish Setup for Investors
- What does consumer price index measure?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How to Calculate Inflation Rate
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.